Log in
Enquire now
‌

Aerosol Dynamics Inc. SBIR Phase I Award, May 2019

A SBIR Phase I contract was awarded to Aerosol Dynamics Inc. in May, 2019 for $143,980.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

OverviewStructured DataIssuesContributors

Contents

sbir.gov/node/1682273
Is a
SBIR/STTR Awards
SBIR/STTR Awards

SBIR/STTR Award attributes

SBIR/STTR Award Recipient
Aerosol Dynamics Inc.
Aerosol Dynamics Inc.
0
Government Agency
0
Government Branch
National Institutes of Health
National Institutes of Health
0
Award Type
SBIR0
Contract Number (US Government)
1R43ES030649-010
Award Phase
Phase I0
Award Amount (USD)
143,9800
Date Awarded
May 1, 2019
0
End Date
October 31, 2020
0
Abstract

Project Summary In recent years the use of engineered nanomaterialsENMshas exponentially increasedThese materials have been incorporated in new or developing technologiesand industries worldwide are using these nanomaterials as integrated sensorssemiconductorsdrug delivery systemsstructural materialsand components of sunscreens and cosmeticsclothing and children s toysThe principal properties that differentiate ENM from other materials are increased relative surface areaand high quantum effects which can change or enhance several properties of the manufactured materialsincluding their reactivitystrength and electrical characteristicsHoweverthese characteristics may also confer other detrimental properties related to their biological toxicityhigh rate of pulmonary deposition and high inflammatory potency per unit massamong otherswhich may lead to adverse health effectsEven though the number of ENMs entering the market is increasing every yearthere is a lack of information regarding the degree and conditions in which workers and consumers are exposed to ENMs and their potential adverse health outcomesIn vitro studies conducted with carbon nanotubes and titanium dioxide nanoparticles have provided inconsistent results regarding toxicityDifferences in ENM aerosolization and sampling methodsexposure mechanism and dosecell line and conducted cytotoxicity assayscontribute to these discrepancies in the resultsHoweverthe greatest challenges are associated with particle deliveryexposure mechanismand dosimetryIn additioncommon in vitro models use submerged cell cultures which is a simplistic representation of human lungIn recent yearsmore realistic cell cultures in the air liquid interfaceALIhave been used for assessing biological outcomes of airborne particles in generalAs a resultaerosol exposure chamberswhich culture and expose multiple ALI cells to aerosolized nanoparticles have been developedAlthough these systems provide new tools to study the toxicity of airborne particles there are still many shortcomingslong exposure timesdosimetry characterizationreduced particle deposition in the nanometer size rangelarge size and heavy weightetcthat must be resolved before their wide scale acceptanceHere we proposed the adaptation of a newly developed airborne particle delivery technology for efficient and reliable exposure of ALI cells to ENMs in both working and indoor environments Project Narrative Human exposure to engineered nanomaterialsENMscan occur in different environmentsfrom occupational settings during fabrication and handlingto homes while using consumer products containing ENMsTo assess the risks associated with exposure to the staggering number of ENMs produced annuallywe need to better understand their hazardswith emphasis in their toxicological propertiesHere we present a new system that can increase accuracy in the assessment of toxicological properties of ENMs by directly exposing lung cells to airborne ENMs

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Aerosol Dynamics Inc. SBIR Phase I Award, May 2019

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.